Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 13, 327-334, April 1, 1953]
© 1953 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wooley, D. W.
Right arrow Articles by Townsend, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wooley, D. W.
Right arrow Articles by Townsend, P.

Transient Regression of Murine Spontaneous Mammary Tumors with Analogs of Dimethyldiaminobenzene

D. W. Wooley, G. Schaffner and P. Townsend

( Laboratories of The Rockefeller Institute for Medical Research, New York, N.Y.)

1,2-Dimethyl-4-amino-5-hydroxybenzene (DMAP), an antimetabolite of 1,2-dimethyl-4,5-diaminobenzene, caused some spontaneous mammary tumors of Swiss or of C strain mice to decrease in size or to disappear. More than half of the treated animals were not thus affected by this substance. In most of the affected animals the tumor decreased in size but did not disappear. In every instance of regression, the effect was transient, and eventually the tumor grew once more and killed the host. The DMAP was not detectably toxic to adult mice. A satisfactory quantitative method for the estimation of DMAP in mouse tissues was described. Mice were found to destroy or to excrete DMAP injected into them, but 12–40 per cent of a single dose could be recovered from a mouse 5 hours after administration. Individual mice of the single Swiss strain were observed to differ with respect to the percentage of an injected dose which they destroyed. Although the proportion of mice actively destroying DMAP corresponded roughly to the proportion of tumorous mice which did not respond to this compound, the magnitude of the difference in capacity to destroy DMAP was not considered great enough to explain completely why some tumors were caused to regress and others were not. The reappearance of obliterated tumors was not associated with the acquisition of great ability to destroy DMAP. However, all mice in which tumors had been caused to regress by injection of DMAP showed less than average capacity to destroy the drug.

A barely perceptible effect in causing regression of spontaneous mammary tumors in C and in C3H mice was observed with another antimetabolite of dimethyldiaminobenzene, viz., 1,2-dichloro-4,5-diaminobenzene. A quantitative method for the estimation of this compound in mouse tissues was developed. The use of this method revealed that mice readily destroyed this substance.

One-half of a group of Swiss mice bearing spontaneous mammary tumors exhibited either a decrease in size or a complete obliteration of the tumors when the animals were injected daily with a mixture of 1,2-dimethyl-4-(p-carboxyphenylazo)-5-hydroxybenzene and 1,2-dichloro-4-(p-nitrobenzenesulfonylamido)-5-nitrobenzene. These aggregate analogs of dimethyldiaminobenzene and p-aminobenzoic acid were not able to cause permanent destruction of the tumors, because those which had been obliterated reappeared after several months.

Received 10/30/52.


This article has been cited by other articles:


Home page
ScienceHome page
C. P. Rhoads
Rational Cancer Chemotherapy
Science, January 15, 1954; 119(3081): 77 - 80.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1953 by the American Association for Cancer Research.